Spots Global Cancer Trial Database for tumor necrosis factor
Every month we try and update this database with for tumor necrosis factor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | NCT01351805 | Autoimmune Dise... Systemic Inflam... Knee Pain Chron... Osteoarthritis Rheumatoid Arth... | Fish Oil Vitamin D placebo pill | 50 Years - | Brigham and Women's Hospital | |
Study Evaluating Etanercept in Moderate to Severe Asthma | NCT00141791 | Asthma | Etanercept | 18 Years - 70 Years | Wyeth is now a wholly owned subsidiary of Pfizer | |
The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients | NCT00000860 | Mycobacterium A... HIV Infections | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | ||
Etanercept for Wegener's Granulomatosis | NCT00005007 | Wegener's Granu... | Etanercept | 11 Years - | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |
OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants | NCT05909852 | Adalimumab | ABP 501-HCF ABP 501-LCF | 18 Years - 55 Years | Amgen | |
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis | NCT01504113 | Psoriasis | 20 Years - 90 Years | National Taiwan University Hospital | ||
Effects of Spinal Manipulative Treatment on Inflammatory Markers in Low Back Pain Patients | NCT01766141 | Low Back Pain | Spinal manipula... | 20 Years - 60 Years | Canadian Memorial Chiropractic College | |
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis | NCT00794274 | Sarcoidosis Cutaneous Sarco... | CC-100004 | 18 Years - 80 Years | University of Cincinnati | |
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma | NCT00001893 | Asthma | TNFR:Fc | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis | NCT05073315 | Plaque Psoriasi... | Adalimumab ABP 501 | 18 Years - 75 Years | Amgen | |
Treatment of Pulmonary Sarcoidosis With Pentoxifylline | NCT00001877 | Pulmonary Sarco... | Pentoxifylline | - | National Institutes of Health Clinical Center (CC) | |
Efficacy of Epidural Etanercept in the Treatment of Sciatica | NCT00364572 | Sciatica | epidural inject... placebo (contro... | 18 Years - 70 Years | Johns Hopkins University | |
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children | NCT00006064 | HIV Infections HIV Wasting Syn... Lipodystrophy | 1 Month - 12 Years | National Institute of Allergy and Infectious Diseases (NIAID) | ||
Study Evaluating Etanercept in Moderate to Severe Asthma | NCT00141791 | Asthma | Etanercept | 18 Years - 70 Years | Wyeth is now a wholly owned subsidiary of Pfizer | |
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma | NCT00002262 | Sarcoma, Kaposi HIV Infections | Tumor Necrosis ... | 18 Years - 70 Years | NIH AIDS Clinical Trials Information Service | |
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | NCT01269203 | Multiple Myelom... | Curcumin Placebo | 18 Years - | M.D. Anderson Cancer Center | |
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis | NCT05073315 | Plaque Psoriasi... | Adalimumab ABP 501 | 18 Years - 75 Years | Amgen | |
Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis | NCT02762955 | Psoriasis | BCD-057 Humira® | 18 Years - 75 Years | Biocad | |
Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis | NCT02762955 | Psoriasis | BCD-057 Humira® | 18 Years - 75 Years | Biocad | |
OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | NCT00001296 | Melanoma | melphalan tumor necrosis ... interferon-gamm... hyperthermic is... | - | National Institutes of Health Clinical Center (CC) | |
Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) | |
Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS | NCT00000646 | HIV Infections | Pentoxifylline | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
Apremilast Pregnancy Exposure Registry | NCT02775500 | Psoriatic Arthr... Psoriasis | apremilast | - | University of California, San Diego | |
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | NCT00001296 | Melanoma | melphalan tumor necrosis ... interferon-gamm... hyperthermic is... | - | National Institutes of Health Clinical Center (CC) | |
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | NCT01269203 | Multiple Myelom... | Curcumin Placebo | 18 Years - | M.D. Anderson Cancer Center | |
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa | NCT01635764 | Hidradenitis Su... | adalimumab | 18 Years - | AbbVie | |
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa | NCT01635764 | Hidradenitis Su... | adalimumab | 18 Years - | AbbVie | |
OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
Use of Thalidomide in Patients With Arachnoiditis | NCT00284505 | Arachnoiditis | thalidomide | 18 Years - 85 Years | Washington University School of Medicine | |
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex | NCT00001004 | HIV Infections | Tumor Necrosis ... Interferon gamm... | 18 Years - 70 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex | NCT00001004 | HIV Infections | Tumor Necrosis ... Interferon gamm... | 18 Years - 70 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus | NCT06135259 | Oral Lichen Pla... | erythropoietin Triamcinolone a... | 25 Years - 60 Years | Ain Shams University | |
Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) |